EFPIA - NEWSLETTER

EFPIA Newsletter 12 October 2023

How can innovation help address workforce shortages?

With 5 new cancer patients diagnosed every minute in Europe, experts estimate that the region will see a shortage of 4.1 million healthcare workers by 2030. This will put significant pressure on oncology care, resulting in delayed diagnoses and poorer health outcomes for patients, more pressurised staff and the subsequent impact on mental health, as well as an increasing number of staff shortages and longer waiting lists.

Read EFPIA's latest report on Innovation for Sustainable Cancer Care.

Rethinking Alzheimer's Disease | Watch the event recording

Based on key findings of the Rethinking Alzheimer’s Disease White Paper: Detection & Diagnosis.

Events

16 OCT 2023

33rd Alzheimer Europe Conference Helsinki, Finland, & virtual

New opportunities in dementia care, policy and research

Learn more →

17 OCT 2023

EFGCP Better Medicines for Children Conference 2023 Amsterdam

Global Paediatric Drug Development: the value of multi-stakeholders’ collaboration

Learn more →

06 NOV 2023

World Local Production Forum The Hague, the Netherlands

Enhancing access to medicines and other health technologies

Learn more →

07 NOV 2023

High-Level Conference on the Value and Role of Incentives in Life Science Brussels, Belgium

Under the auspices of the Ministry of Health of the Czech Republic

Learn more →

More than 600 essential medicines at risk with new EU chemical proposal

Evidence shows that more than 600 essential medicines are at risk, and manufacturing in Europe will ‘grind to a halt’ if wide-ranging chemical ban on Per- and Polyfluoroalkyl Substances (PFAS) substances is implemented.

While we support the need to restrict certain PFAS, we need to find the right approach to ensure the continued manufacturing and availability of medicines in Europe. A total ban would see medicines’ manufacturing in the EU grind to a halt in under three years. It would also jeopardise the production of all pharmaceutical substances in Europe and would be in conflict with the EU’s strategy of reducing Europe's dependency in the event of shortages or pandemics.

Discover more here.

What we are reading

What’s in a name? Why unmet medical needs are riling the pharma industry 12 October 2023 (Politico)

How is the EU boosting support for innovation in the health sector? 05 October 2023 (Euronews)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶